North China Pharmaceutical Company. Ltd. provided earnings guidance for the first half of 2018. For the period, the company predicts an increase of RMB 31 million in the net profit belonging to shareholders compared with the same period of the year before, with a year-on-year increase of about 100%. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by RMB32.7 million compared with the same period of the year before, with a year-on-year increase of about 190%.